Korean Drug Co. Ltd (014570) - Total Liabilities

Latest as of March 2026: ₩14.09 Billion KRW ≈ $9.55 Million USD

Based on the latest financial reports, Korean Drug Co. Ltd (014570) has total liabilities worth ₩14.09 Billion KRW (≈ $9.55 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Korean Drug Co. Ltd to track the company's year-over-year net asset growth rate.

Korean Drug Co. Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Korean Drug Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 014570 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Korean Drug Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Korean Drug Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Kyobo 8 Special Purpose Acquisition Company KQ:307280	Korea	₩7.69 Billion
Comelf SA RO:CMF	Romania	RON88.51 Million
Myungmoon Phar KO:017180	Korea	₩168.00 Billion
Advancecon Holdings Bhd KLSE:5281	Malaysia	RM387.83 Million
Choo Bee Metal Industries Bhd KLSE:5797	Malaysia	RM10.62 Million
Seoulin Bioscience Co.Ltd KQ:038070	Korea	₩32.75 Billion
Desane Group Holdings Ltd AU:DGH	Australia	AU$35.11 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Korean Drug Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Korean Drug Co. Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.63	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.17	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.15	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Korean Drug Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Korean Drug Co. Ltd (2014–2025)

The table below shows the annual total liabilities of Korean Drug Co. Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩11.25 Billion ≈ $7.62 Million	+4.32%
2024-12-31	₩10.78 Billion ≈ $7.31 Million	-14.56%
2023-12-31	₩12.62 Billion ≈ $8.55 Million	+28.72%
2022-12-31	₩9.80 Billion ≈ $6.64 Million	-17.77%
2021-12-31	₩11.92 Billion ≈ $8.08 Million	-4.42%
2020-12-31	₩12.47 Billion ≈ $8.45 Million	+15.50%
2019-12-31	₩10.80 Billion ≈ $7.32 Million	+6.27%
2018-12-31	₩10.16 Billion ≈ $6.89 Million	+3.48%
2017-12-31	₩9.82 Billion ≈ $6.66 Million	+0.73%
2016-12-31	₩9.75 Billion ≈ $6.61 Million	+2.42%
2015-12-31	₩9.52 Billion ≈ $6.45 Million	-28.88%
2014-12-31	₩13.38 Billion ≈ $9.07 Million	--

About Korean Drug Co. Ltd

KQ:014570 Korea Drug Manufacturers - General

Market Cap

$24.65 Million

₩36.38 Billion KRW

Market Cap Rank

#24368 Global

#1706 in Korea

Share Price

₩3360.00

Change (1 day)

+1.51%

52-Week Range

₩3120.00 - ₩4710.00

All Time High

₩13030.58